Kojima Chiari, Yumura Wako, Itabashi Mitsuyo, Iwamoto Masae, Shiohira Shunji, Yabuki Yasuko, Takei Takashi, Uchida Keiko, Nitta Kosaku
Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
Nihon Jinzo Gakkai Shi. 2005;47(8):876-81.
A 69-year-old woman, who had been diagnosed with interstitial pneumonia at 66 years of age, was admitted to our hospital because of high fever, purpura occurring on her arms and legs, and renal dysfunction. At the time of admission, her renal function had severely deteriorated (sCr 8.2 mg/dl, 24 h Ccr 6 ml/min), she had a severe high fever (BT 39.5 degrees C), back pain, a white blood cell count of 19,540/,microl, and a CRP level of 26.7 mg/dl. Blood and urine cultures yielded identical strains of E. coli. We diagnosed sepsis caused by pyelonephritis, and started intravenous meropenem trihydrate(MEPM) at 0.5 g/day. Her renal dysfunction was severe, so we started hemodialysis therapy. Immunological examination revealed the presence of ANCA-associated glomerulonephritis. Renal biopsy before steroid therapy confirmed the diagnosis of pauci-immune-type crescentic glomerulonephritis. Based on purpura and interstitial pneumonia, along with rapidly MPO-ANCA-positive progressive glomerulonephritis (RPGN) with acute renal failure, we diagnosed microscopic polyangitis (MPA). To treat sepsis and severe pyelonephritis, we started intravenous immunoglobulin 5 g (100 mg/kg)/day for 5 days before starting immunosuppressive steroid therapy (m-PSL 1 g/day, PSL 20 mg/day) for 3 days. These treatments improved her general condition and immediately improved her renal function. It is important to prevent infection during treatment using conventional immunosuppressive therapy. These findings suggest immunoglobulin therapy to be a safe immuno-suppressive treatment that is efficacious against ANCA-associated glomerulonephritis.
一名69岁女性,66岁时被诊断为间质性肺炎,因高热、四肢出现紫癜及肾功能不全入住我院。入院时,她的肾功能严重恶化(血清肌酐8.2mg/dl,24小时肌酐清除率6ml/min),高热(体温39.5摄氏度),背痛,白细胞计数19540/μl,C反应蛋白水平26.7mg/dl。血培养和尿培养均分离出相同菌株的大肠杆菌。我们诊断为肾盂肾炎所致脓毒症,开始静脉滴注三水美罗培南(MEPM),剂量为0.5g/天。她的肾功能不全严重,因此开始血液透析治疗。免疫检查发现存在抗中性粒细胞胞浆抗体相关性肾小球肾炎。激素治疗前的肾活检确诊为少免疫型新月体性肾小球肾炎。基于紫癜、间质性肺炎,以及快速进展的髓过氧化物酶抗中性粒细胞胞浆抗体(MPO-ANCA)阳性的进行性肾小球肾炎(RPGN)伴急性肾衰竭,我们诊断为显微镜下多血管炎(MPA)。为治疗脓毒症和严重肾盂肾炎,在开始免疫抑制性类固醇治疗(甲泼尼龙1g/天,泼尼松20mg/天)3天前,我们先开始静脉注射免疫球蛋白5g(100mg/kg)/天,共5天。这些治疗改善了她的一般状况,并立即改善了她的肾功能。在使用传统免疫抑制治疗期间预防感染很重要。这些发现表明免疫球蛋白治疗是一种安全的免疫抑制治疗方法,对抗中性粒细胞胞浆抗体相关性肾小球肾炎有效。